COVID-19 and metabolic disease: mechanisms and clinical management

Steenblock, C.; Schwarz Peter, E.H.; Ludwig, B.; Linkermann, A.; Zimmet, P.; Kulebyakin, K.; Tkachuk, V.A.; Markov, A.G.; Lehnert, H.; de Angelis, M.H.; Rietzsch, H.; Rodionov, R.N.; Khunti, K.; Hopkins, D.; Birkenfeld, A.L.; Boehm, B.; Holt Richard, I.G.; Skyler, J.S.; DeVries, J.H.; Renard, E.; Eckel, R.H.; Alberti George, K.M.; Geloneze, B.; Chan, J.C.; Mbanya, J.C.; Onyegbutulem, H.C.; Ramachandran, A.; Basit, A.; Hassanein, M.; Bewick, G.; Spinas, G.A.; Beuschlein, F.; Landgraf, R.; Rubino, F.; Mingrone, G.; Bornstein, S.R.

Статья опубликована в высокорейтинговом журнале

Информация о цитировании статьи получена из Web of Science, Scopus
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 12 января 2022 г.

Авторы: Steenblock Charlotte, Schwarz Peter E.H., Ludwig Barbara, Linkermann Andreas, Zimmet Paul, Kulebyakin Konstantin, Tkachuk Vsevolod A., Markov Alexander G., Lehnert Hendrik, de Angelis Martin Hrabě, Rietzsch Hannes, Rodionov Roman N., Khunti Kamlesh, Hopkins David, Birkenfeld Andreas L., Boehm Bernhard, Holt Richard I.G., Skyler Jay S., DeVries J.Hans, Renard Eric, Eckel Robert H., Alberti George K.M.M, Geloneze Bruno, Chan Juliana C., Mbanya Jean Claude, Onyegbutulem Henry C., Ramachandran Ambady, Basit Abdul, Hassanein Mohamed, Bewick Gavin, Spinas Giatgen A., Beuschlein Felix, Landgraf Rüdiger, Rubino Francesco, Mingrone Geltrude, Bornstein Stefan R.
Журнал: LANCET DIABETES & ENDOCRINOLOGY
Том: 9
Номер: 11
Год издания: 2021
Первая страница: 786
Последняя страница: 798
DOI: 10.1016/S2213-8587(21)00244-8
Аннотация: Up to 50% of the people who have died from COVID-19 had metabolic and vascular disorders. Notably, there are many direct links between COVID-19 and the metabolic and endocrine systems. Thus, not only are patients with metabolic dysfunction (eg, obesity, hypertension, non-alcoholic fatty liver disease, and diabetes) at an increased risk of developing severe COVID-19 but also infection with SARS-CoV-2 might lead to new-onset diabetes or aggravation of pre-existing metabolic disorders. In this Review, we provide an update on the mechanisms of how metabolic and endocrine disorders might predispose patients to develop severe COVID-19. Additionally, we update the practical recommendations and management of patients with COVID-19 and post-pandemic. Furthermore, we summarise new treatment options for patients with both COVID-19 and diabetes, and highlight current challenges in clinical management.
Добавил в систему: Кулебякин Константин Юрьевич

	ИСТИНА	Войти в систему Регистрация
	ИСТИНА ЦЭМИ РАН
	Главная Поиск Статистика О проекте Помощь

ИСТИНА

ИСТИНА ЦЭМИ РАН

COVID-19 and metabolic disease: mechanisms and clinical managementстатья

Прикрепленные файлы